The reference to cancer stages (I, II, III and IV) in a cancer diagnosis comes from the international  TNM (“Tumour”, “Nodes”, “Metastases”) classification system, which describes how advanced a cancer is. It has been maintained by UICC for the past 70 years, and every year the Core Committee meets to discuss updates to the system.

Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, marks UICC's 90th year by highlighting WHO's partnership with UICC and the progress made together in reducing the burden of cancer around the world.

Individuals and organisations across the globe joined with UICC, its members and partners and the entire cancer community to make the World Cancer Day “Close the care gap” campaign another resounding success in 2023.

A new analysis by the Access to Oncology Medicines (ATOM) Coalition, published by UICC, takes a closer look at the gaps and opportunities in access-related capacity building programmes in low- and lower-middle income countries. 

WHO is set to release a Framework aimed integrating the lived experience of people living with health conditions, ensuring that the participation of patients is guaranteed as a core concept in the design and development of healthcare practices and policies.

The right to health is one of the fundamental human rights for the well-being of every individual. However, these rights are often denied to cancer patients. Addressing these barriers requires a multifaceted approach encompassing universal health coverage, cancer control plans, the use of legislation and fulfilling state obligations.